API Solutions
API Solutions
EUROAPI offers one of the largest API portfolios in the world, numbering nearly 200 ingredients, addressing a wide variety of patients and providing global coverage to more than 80 countries.
Vitamin B12
Vitamin B12, or cobalamin, fuels some of the body’s most essential processes, including DNA synthesis, red blood cell production, and nervous system regulation.
Its production is based on a complex fermentation process that was developed by EUROAPI as early as 1966.
As the pharmaceutical industry’s sole Western manufacturer of vitamin B12, EUROAPI plays a crucial role in ensuring its global supply.
Prostaglandins
Prostaglandins have a multitude of useful applications in healthcare.
As the holder of the largest prostaglandin API production facility in the world, EUROAPI is the world’s leading supplier of prostaglandins for large-scale commercial pharmaceutical production.
Corticoids and hormones
Corticoids and hormones easily rank among the most versatile and widely-used APIs today. Both these API families have widespread applications in both human health and veterinary care.
Backed by nearly 70 years of expertise, EUROAPI has the largest corticoid portfolio on the market and is the only European corticoids manufacturer offering a fully integrated production process.
Anti-infectives
From tuberculosis to meningitis and MRSA infections, anti-infectives are critical in treating a range of infections. EUROAPI offers a comprehensive suite of anti-infective APIs from its renowned site in Brindisi, Italy.
Opiates & controlled substances
We have secured an exclusive sourcing of some 10,000 hectares of poppy field, from French farmers. EUROAPI oversees the seed-to-shelves production of an expanding portfolio of opiates, and also molecules from the “Nals” family.
Small and complex molecules
From over-the-counter analgesics to life-saving treatments for cardiovascular disease, small molecule synthesis is central to the development and effectiveness of countless pharmaceutical therapies.
EUROAPI’s current synthesis portfolio includes around 60 small and complex molecule API references that span a highly diverse range of therapeutic uses for both humans and animals.